Correlate the following clinical scenarios involving suspected central nervous system infe… — USMLE Step 2 CK

Correlate the following clinical scenarios involving suspected central nervous system infections with the most appropriate empiric or targeted pharmacotherapy.

A 72-year-old female with hypertension arrives at the emergency department with acute high fever, photophobia, and stiff neck. Lumbar puncture demonstrates neutrophilic pleocytosis and hypoglycorrhachia.Intravenous ceftriaxone, vancomycin, and ampicillin
A 32-year-old male with an absolute CD4 count of $35 \text{ cells/mm}^3$ experiences subacute confusion and lethargy. Cerebrospinal fluid analysis reveals a mononuclear pleocytosis and an opening pressure of $320 \text{ mm H}_2\text{O}$ .Intravenous liposomal amphotericin B and flucytosine
A 28-year-old forestry worker reports left-sided facial weakness and a severe headache. He recalls an erythematous expanding rash on his leg four weeks prior. Cerebrospinal fluid shows lymphocytic pleocytosis.Intravenous ceftriaxone
A 45-year-old male is brought in by family due to rapidly progressive disorientation, fever, and olfactory hallucinations. Brain imaging shows unilateral temporal lobe edema, and cerebrospinal fluid contains elevated erythrocytes.Intravenous acyclovir
A 40-year-old female recovering on postoperative day five from a craniotomy for a benign meningioma develops high fever and nuchal rigidity. Cerebrospinal fluid analysis demonstrates significant neutrophilic pleocytosis.Intravenous vancomycin and cefepime

Answer

1: Empiric bacterial meningitis >50 years is treated with ceftriaxone, vancomycin, and ampicillin. 2: Cryptococcal meningitis is treated with liposomal amphotericin B and flucytosine. 3: Neurologic Lyme disease is treated with intravenous ceftriaxone. 4: HSV encephalitis is treated with intravenous acyclovir. 5: Post-neurosurgical meningitis is treated with vancomycin and cefepime.

Each clinical scenario uniquely points to a distinct central nervous system infection etiology requiring a specific therapeutic approach based on current Infectious Diseases Society of America (IDSA) guidelines.

Step-by-Step Solution

Analyze each patient's demographic profile, exposure history, and immune status.

Identified a healthy older adult, a severely immunocompromised HIV patient, an outdoor worker with a previous erythema migrans rash, an adult with rapidly progressive encephalopathy, and a post-neurosurgical patient.

Host factors and epidemiologic exposures dictate the most likely etiology of central nervous system infections.

Evaluate the localized signs and cerebrospinal fluid (CSF) findings.

Correlated neutrophilic pleocytosis with bacterial meningitis, mononuclear pleocytosis with elevated pressure to fungal/cryptococcal infection, hemorrhagic CSF with temporal lobe edema to HSV, and lymphocytic pleocytosis with facial palsy to neurologic Lyme.

CSF profiles (neutrophilic vs. lymphocytic/mononuclear) and imaging findings help differentiate bacterial, viral, fungal, and spirochetal causes.

Select the guideline-recommended antimicrobial regimen for each specific diagnosis.

Matched age-based bacterial coverage, targeted fungal induction therapy, anti-spirochetal cephalosporin therapy, antiviral therapy, and anti-pseudomonal/MRSA coverage accordingly.

Delivering precise empiric or targeted therapy prevents significant morbidity and mortality associated with central nervous system infections.

Key Concept

Selection of empiric and targeted antimicrobial regimens for central nervous system infections must be strictly tailored to patient age, immune status, unique exposures, and specific cerebrospinal fluid profiles.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic